HSP90AA1 and urinary bladder cancer: However, increasing Hsp90 acetylation through HDAC inhibition with ACY-241 resulted in enhanced Hsp90 inhibitor binding as well as sensitization to Hsp90 inhibitors in the TSC1 mutated RT4 bladder cancer cell line.